Vanderbilt University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Vanderbilt University sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).
Vanderbilt University: 430 sponsored US clinical trials, 15 recruiting.
Vanderbilt University sponsors 430 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 343 completed. 42 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
Vanderbilt University ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
343 of 401 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
430 total, page 2 of 9
EMT en Español for Spanish-speaking Toddlers With Language Delays
NCT04066049
Improving the Academic Performance of First-Grade Students With Reading and Math Difficulty
NCT03991234
TelePORT Pilot Study
NCT03926533
Tailoring a Lifestyle Intervention to Address Obesity Disparities Among Men
NCT03037502
Literacy and Language Interventions Via Telepractice for School-Age Children
NCT03878641
Disruptive bEhavior manageMEnt ANd Prevention in Hospitalized Patients Using a behaviORal Intervention Team
NCT03777241
CBT Enhanced With Social Cognitive Training
NCT03954392
Enhancing Coping and Communication in Children With Cancer and Their Parents
NCT05051800
Improving Response to Intervention in Students With or at Risk of Reading Disabilities
NCT03261661
Putative Cognitive Enhancer VU319
NCT03220295
COgnitive and Physical Exercise (COPE) Prehabilitation Pilot Feasibility Study
NCT03094988
Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children
NCT02712996
Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)
NCT02971202
Mobility and Therapeutic Benefits Resulting From Exoskeleton Use in a Clinical Setting (SC140121 Study 1 and 2)
NCT03082898
The Impact of Non-Routine Events on Neonatal Safety
NCT02756195
Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
NCT02927223
Check It! 2.0: Positive Psychology Intervention for Adolescents With Type 1 Diabetes
NCT02984709
MRI Diffusion Tensor Tractography to Monitor Peripheral Nerve Recovery After Severe Crush or Cut/Repair Nerve Injury
NCT02960516
New Formulations of Propafenone to Treat Atrial Fibrillation
NCT02710669
Atlas Predicted DBS Settings in Essential Tremor
NCT02678429
Identifying Diuretic Resistance in Patients With Acute Heart Failure
NCT02751242
Continuous Supraglottic pH Monitoring in Prolonged Intubated Intensive Care Patients and High Risk Aspiration Intraoperative Patients
NCT02604043
Stress Index to Individualize Mechanical Ventilation in ARDS
NCT02871102
The Natriuretic Peptide System in African-Americans.
NCT02730780
Collaboration for Antepartum Risk Evaluation
NCT02786225
Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
NCT02625181
Virtual Reality Training for Social Skills in Schizophrenia
NCT03128099
Intrathecal (IT) Baclofen Drug Distribution
NCT02903823
Risk of Oxygen During Cardiac Surgery Trial
NCT02361944
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
NCT02745301
Decision Making Study in Young and Middle-Aged Adults: Part II
NCT03512171
Efficacy of IMPACT in Infant Siblings of Children With ASD
NCT03274622
A ED-based Intervention to Improve Antihypertensive Adherence
NCT02672787
Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
NCT02606253
The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
NCT02122380
Saline Against Lactated Ringers or Plasmalyte in the Emergency Department
NCT02614040
Neuroinflammation and Postoperative Delirium in Cardiac Surgery
NCT02688179
The SCCS Polypill Pilot Trial
NCT02278471
Effect of DPP4 Inhibition on Vasoconstriction
NCT02639637
Meal Schedule Effects on Circadian Energy Balance in Adults
NCT04144426
Isotonic Solutions and Major Adverse Renal Events Trial in the Non-Medical Intensive Care Unit (SMART-SURG)
NCT02547779
Once Versus Twice Daily Electrolyte Monitoring in CHF
NCT02497742
Get With the Guidelines in ED Patients With Heart Failure
NCT02519283
The Diabetes Medication Adherence Promotion Intervention Trial
NCT02458495
2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients
NCT02490631
Use of 2% Chlorhexidine Cloths Reduce Surgical Site Infections
NCT02385708
Checklists and Upright Positioning in Endotracheal Intubation of Critically Ill Patients (Check-UP) Trial
NCT02497729
Communication Intervention for Toddlers With Autism
NCT02595697
Actigraphy to MEasuRe Intensive Care Unit Activity
NCT02263716
Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit
NCT02444988
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 50 |
| Phase 2 | 42 |
| Phase 3 | 10 |
| Phase 4 | 32 |
Therapeutic Areas
What is open in the Vanderbilt University pipeline
15 recruiting of 430 indexed (3% open); 343 completed (80%).
Phase mix: 42 late (III/IV) vs 92 early (I/II) (early-phase heavy).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Vanderbilt University: open-pipeline peers nationwide
Peers matched on 430 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 430 trials (± recruiting share)
- University of Illinois at Chicago · 430 trials · 27% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 3% open enrollment (± trial volume)
- USDA Grand Forks Human Nutrition Research Center · 4% recruiting · 57 trials
- Medtronic MiniMed · 3% recruiting · 29 trials
- Sandoz · 3% recruiting · 29 trials
- Sonova · 3% recruiting · 29 trials
Related
What to do with this Vanderbilt University page
430 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University or any single study.
- 15 of Vanderbilt University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Vanderbilt University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Vanderbilt University pipeline card: 430 registered trials from official public datasets.Report a data error.